About Questus Pharma
Questus Pharma is a company based in Madhapur (India) founded in 2021. It operates as a B2B. The company has 97 employees. Questus Pharma offers products and services including Cardiology Formulations, Critical Care Formulations, and Pain Management Formulations. Questus Pharma operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Madhapur, India
- Employees 97
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website questuspharma.com
- Legal Name Questus Pharma Private Limited
- Date of Incorporation 11 Aug, 2021
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹38.87 Cr
FY 2025 · -10% YoY
- Net Profit₹15.9 Lakh
FY 2025 · 0% margin
- EBITDA₹81.9 Lakh
FY 2025 · 2% margin
- Employee Count97
Associated legal entities of Questus Pharma
Questus Pharma operates through Questus Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Questus Pharma Private Limited CIN U24239TG2021PTC154020 | Active | 11 Aug 2021 | Hyderabad, Telangana | ₹38.9 Cr | 97 | 6 | View details |
Products & Services of Questus Pharma
Questus Pharma offers a comprehensive portfolio of products and services, including Cardiology Formulations, Critical Care Formulations, and Pain Management Formulations.
Medicines for treating heart-related conditions and cardiovascular health.
Drugs for intensive care and life-support treatments.
Treatments for effective pain relief and management.
Board of directors of Questus Pharma Private Limited (Questus Pharma)
Questus Pharma Private Limited is the primary company behind Questus Pharma. The board of Questus Pharma Private Limited currently have 5 directors; the longest-serving is Raghuveer Adusumilli, appointed in 2022. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raghuveer Adusumilli DIN 05215341 | Director | 25 Nov 2022 | 3 yrs 10 mo | Questus Pharma Private Limited |
| Asheesh Bhatnagar DIN 09800634 | Whole-time director | 16 Dec 2022 | 3 yrs 9 mo | Questus Pharma Private Limited |
| Appalaneni Rajendra Prasad DIN 03315589 | Director | 04 Jan 2023 | 3 yrs 9 mo | Questus Pharma Private Limited |
| Pameela Paruchuri DIN 03620183 | Company Secretary | 13 Sep 2023 | 3 yrs | Questus Pharma Private Limited |
| Nagesh Kumar Middey DIN 03625581 | Director | 09 Oct 2023 | 3 yrs | Questus Pharma Private Limited |
Financials of Questus Pharma
Figures of Questus Pharma Private Limited, the primary company behind Questus Pharma, for FY 2025. Revenue was ₹38.87 Cr (-10% year on year). Net profit was ₹15.9 Lakh (0% margin). EBITDA was ₹81.9 Lakh (2% margin). Revenue has grown at a compounded annual rate of +93% over three years.
- ₹38.87 CrRevenue · FY 2025 · -10% YoY
- ₹15.9 LakhNet profit · 0% margin
- ₹81.9 LakhEBITDA · 2% margin
- ₹24.76 CrPaid-up capital
- 97Employees (provident fund records)
- +93%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Questus Pharma Private Limited are on its company page.
Detailed financial statements for Questus Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Questus Pharma
Questus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| merck.com | 1891 | Kenilworth, United Kingdom | – | 781 | Pharmaceutical products are manufactured and marketed worldwide. | |
| roivant.com | 2014 | New York, United States | $1.3B | 662 | Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | |
| abbvie.com | 2012 | Chicago, United States | – | 8,667 | Biopharmaceutical research and drug development are conducted globally by AbbVie. | |
| gilead.com | 1987 | Foster, United States | – | 4,267 | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | |
| lilly.com | 1876 | United States | – | 39,000 | Traditional pharmaceutical medicines are developed for multiple health fields. | |
| vrtx.com | 1989 | United States | – | 5,400 | Developer of drugs for the treatment of multiple disorders | |
| morphosys.com | 1992 | Planegg, Germany | – | 732 | Therapeutic antibodies for cancer and other diseases are developed. | |
| roche.com | 1896 | Basel, Switzerland | – | 2,382 | Pharmaceuticals and diagnostics kits are developed for various diseases. | |
| unither.com | 1998 | Silver Spring, United States | – | 1,168 | Treatments for chronic and life-threatening diseases are developed and commercialized. | |
| ascendispharma.com | 2007 | Hellerup, Denmark | $108.7M | 573 | Long-acting prodrug therapies are developed for endocrine and rare diseases. |
Detailed competitors of Questus Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Questus Pharma
The website of Questus Pharma (questuspharma.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 1% vs previous month
Similar companies to Questus Pharma
10 companies that operate in the same segment as Questus Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Questus Pharma
Questus Pharma was founded in 2021.
Questus Pharma is headquartered in Madhapur, India. It is registered at Madhapur, Telangana, India.
Questus Pharma has 97 employees.
The primary company behind Questus Pharma, Questus Pharma Private Limited, reported revenue of ₹38.87 Cr for FY 2025, down 10% year on year.
Questus Pharma Pvt. Ltd., based in Hyderabad, India, specializes in creating affordable pharmaceutical formulations for cardiology, critical care, and pain management. They operate with advanced RD and manufacturing facilities, serving patients across five continents through partnerships. The company emphasizes quality innovation and accessibility in healthcare, focusing on meeting international standards while improving treatment outcomes.
Questus Pharma's top competitors include Merck, Roivant Sciences and AbbVie.
Questus Pharma offers Cardiology Formulations, Critical Care Formulations, and Pain Management Formulations.
Questus Pharma operates through Questus Pharma Private Limited.
The legal entities of Questus Pharma currently have 5 directors, including Nagesh Kumar Middey, Raghuveer Adusumilli, Asheesh Bhatnagar and others.